← Back to Clinical Trials
Recruiting NCT07411248

NCT07411248 Exercise Approaches and Physical Activity Level in Inactive Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07411248
Status Recruiting
Phase
Sponsor Biruni University
Condition Healthy Participants
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-01-06
Primary Completion 2026-03-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Face-to-Face Supervised ExerciseMobile App-Based ExerciseHome-Based Video Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-01-06 with a primary completion date of 2026-03-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized, controlled, single-blind study aims to compare the effects of different exercise approaches on physical activity level and health-related outcomes in inactive adults. Thirty inactive individuals aged 18-35 years will be randomly assigned to supervised face-to-face group exercise, mobile application-based exercise, or video-based home exercise. Exercise programs will be performed three days per week for eight weeks and will include aerobic, strengthening, and flexibility exercises.

Eligibility Criteria

Inclusion Criteria: * Taking fewer than 5,000 steps per day and classified as physically inactive according to the International Physical Activity Questionnaire-Short Form (\<600 MET-min/week) * Residing in Istanbul * Willingness to participate in the study Exclusion Criteria: * Diagnosis of end-stage congestive heart failure * Presence of malignant or unstable arrhythmia * Lack of adequate infrastructure to participate in technology-based physical activity programs * Presence of mental dysfunction * Presence of acute musculoskeletal injury * Pregnancy * Answering "YES" to any item on the Physical Activity Readiness Questionnaire (PAR-Q)

Contact & Investigator

Central Contact

Begüm Kara Kaya, Asst. Prof.

✉ bkara@biruni.edu.tr

📞 +904448276

Frequently Asked Questions

Who can join the NCT07411248 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07411248 currently recruiting?

Yes, NCT07411248 is actively recruiting participants. Contact the research team at bkara@biruni.edu.tr for enrollment information.

Where is the NCT07411248 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07411248 clinical trial?

NCT07411248 is sponsored by Biruni University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology